Curis (CRIS) Total Debt Growth (1y) (2013 - 2024)
Curis (CRIS) Total Debt Growth (1y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-11.15% |
| Dec 31, 2018 |
-14.68% |
| Sep 30, 2018 |
-13.36% |
| Jun 30, 2018 |
-12.28% |
| Mar 31, 2018 |
-11.29% |
| Dec 31, 2017 |
109.41% |
| Sep 30, 2017 |
105.12% |
| Jun 30, 2017 |
99.77% |
| Mar 31, 2017 |
95.63% |
| Dec 31, 2016 |
-17.82% |
| Sep 30, 2016 |
-18.12% |
| Jun 30, 2016 |
-17.53% |
| Mar 31, 2016 |
-16.34% |
| Dec 31, 2015 |
-14.61% |
| Sep 30, 2015 |
-12.16% |
| Jun 30, 2015 |
-10.82% |
| Mar 31, 2015 |
-9.39% |
| Dec 31, 2014 |
-7.38% |
| Sep 30, 2014 |
-4.97% |
| Jun 30, 2014 |
-1.73% |
